Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Tennessee
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Sibutramine

Criteria

Inclusion Criteria:

• In good general health

• Body mass index greater than or equal to 25

• Currently smoke cigarettes